Biohaven Pharma (BHVN) Tops Q2 EPS by 6c, Revenues Beat

Go back to Biohaven Pharma (BHVN) Tops Q2 EPS by 6c, Revenues Beat
(NYSE: BHVN) Delayed: 11.07 --0 (-0%)
Previous Close $11.07    52 Week High
Open $11.07    52 Week Low
Day High $11.07    P/E N/A 
Day Low $11.07    EPS
Volume